Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07DUW
|
||||
| Former ID |
DNC012165
|
||||
| Drug Name |
N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534413] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C10H13N3O4S
|
||||
| Canonical SMILES |
COC1=C(C=C(C=C1)C(=O)N=C(N)N)S(=O)(=O)C
|
||||
| InChI |
1S/C10H13N3O4S/c1-17-7-4-3-6(9(14)13-10(11)12)5-8(7)18(2,15)16/h3-5H,1-2H3,(H4,11,12,13,14)
|
||||
| InChIKey |
JWTRVDCAXVYZOB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium/hydrogen exchanger 3 | Target Info | Inhibitor | [534413] | |
| Sodium/hydrogen exchanger 1 | Target Info | Inhibitor | [534413] | ||
| KEGG Pathway | Proximal tubule bicarbonate reclamation | ||||
| Protein digestion and absorption | |||||
| Bile secretion | |||||
| Mineral absorptionhsa04024:cAMP signaling pathway | |||||
| Cardiac muscle contraction | |||||
| Adrenergic signaling in cardiomyocytes | |||||
| Regulation of actin cytoskeleton | |||||
| Thyroid hormone signaling pathway | |||||
| Salivary secretion | |||||
| Gastric acid secretion | |||||
| Pancreatic secretion | |||||
| Proteoglycans in cancer | |||||
| Reactome | Hyaluronan uptake and degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.